Sibylle Loibl

39PUBLICATIONS
312CO-AUTHORS
Predictive and prognostic markersMolecular targetsPalliative careCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Sep 11, 2026
Evaluation of a Tumor-Informed Molecular Residual Disease Assay in Early Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy, With or Without Atezolizumab.

|Sep 02, 2026
Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial.

|May 19, 2026
Exploratory Analysis of PTEN Deficiency by Immunohistochemistry from the Phase III CAPItello-291 Trial.

|Apr 29, 2026
Challenges and strategies for delivering effective breast cancer care in conflict zones.

|Apr 20, 2026
Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo Trial.

|Oct 02, 2025
Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II Trial.

Thomas E Mürdter, Werner Schroth, Matthew P Goetz

Pageof 7

Frequent Collaborators

22 joint publications

Carsten Denkert

14 joint publications

Michael Untch

14 joint publications

Valentina Nekljudova

12 joint publications

Peter Fasching